After tumor size had reached approximately 100 mm3, the mice received tail vein injections of TAT-IL-24-KDEL (4 mg/kg) with or without YM155 (4 mg/kg) twice a week (total of seven injections each). This evidence concerns the gene IL24 and neoplasm.